Pathstone Family Office’s Nomura Holdings NMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$81.7K Buy
+20,319
New +$80.9K ﹤0.01% 1602
2023
Q2
– Sell
-13,768
Closed -$52.1K – 1293
2023
Q1
$52.1K Sell
13,768
-2,519
-15% -$9.94K ﹤0.01% 1160
2022
Q4
$54.1K Sell
16,287
-260
-2% -$898 ﹤0.01% 1209
2022
Q3
$54.9K Buy
16,547
+2,557
+18% +$9.29K ﹤0.01% 1181
2022
Q2
$49.6K Buy
13,990
+3,057
+28% +$11.7K ﹤0.01% 1020
2022
Q1
$47K Sell
10,933
-707
-6% -$3.19K ﹤0.01% 943
2021
Q4
$50K Buy
11,640
+1,617
+16% +$7.33K ﹤0.01% 876
2021
Q3
$50K Buy
+10,023
New +$50.1K ﹤0.01% 849

Other funds holding NMR

Pathstone Family Office's NMR Position: Q3 2023 in Review

Pathstone Family Office opened a new position in Nomura Holdings (NMR) in Q3 2023: 20,319 shares worth $81.7K. The stake represents ﹤0.01% of the portfolio and ranks #1602 among its holdings. This is a return to the name: Pathstone Family Office previously reported a position in NMR as recently as Q1 2023.

Pathstone Family Office first reported a position in NMR in Q3 2021 and has held it in 8 quarters since. 130 funds tracked by Wall St. Rank hold NMR as of Q3 2023.

  • Pathstone Family Office held 20,319 shares of Nomura Holdings worth $81.7K as of Q3 2023.
  • Nomura Holdings was a new Pathstone Family Office position in Q3 2023.
  • Nomura Holdings made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1602 holding.
  • Pathstone Family Office first reported a position in Nomura Holdings in Q3 2021 and has held it in 8 quarters since.
  • 130 funds tracked by Wall St. Rank held Nomura Holdings as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.